Evidence map›Paper›PMID 30175236›Full record

ArticlemSystems

Coproporphyrin III Produced by the Bacterium

Jessica L Cleary, Shilpa Kolachina, Benjamin E Wolfe, Laura M Sanchez

Open access · goldAbstract read
In one paragraph

Article in mSystems. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Genomic diversity and thermal niches ofApplied and environmental microbiology · 2026
    Article
  2. Review
  3. Metagenomes enriched withMicrobiology resource announcements · 2026
    Article
  4. Article
  5. Article
  6. MALDI-TIMS-MSAnalytical chemistry · 2025
    Article
  7. Article
  8. Review
  9. Heme alters biofilm formation inMicrobiology spectrum · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. ReducingAnalytical chemistry · 2023
    Article
  14. mSphere · 2023
    Article
  15. Article
  16. Article
  17. Prodigiosin-ProducingFoods (Basel, Switzerland) · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jessica L ClearyDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois, USA.
Shilpa KolachinaDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois, USA.
Benjamin E WolfeDepartment of Biology, Tufts University, Medford, Massachusetts, USA.
Laura M SanchezDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-9223-7977
University of Illinois Chicago · USTufts University · US

Funding

UIC Program for Interdisciplinary Careers in Women's Health ResearchK12HD055892 · NICHD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GELLER, STACIE E. · 2007 to 2016
$4.9M
NICHD NIH HHS K12 HD055892
6 · The paper itself

Abstract

Microbial communities of fermented food microbiomes typically exhibit predictable patterns of microbial succession. However, the biochemical mechanisms that control the diversity and dynamics of these communities are not well described. Interactions between bacteria and fungi may be one mechanism controlling the development of cheese rind microbiomes. This study characterizes a specific bacterium-fungus interaction previously discovered on cheese rinds between the bacterium Glutamicibacter arilaitensis (formerly Arthrobacter arilaitensis) and fungi of the genus

Indexed as

Glutamicibacter arilaitensisimaging mass spectrometrynatural rind cheesePenicilliumspecialized metaboliteszinc coproporphyrin III

Identifiers

PMID30175236
PMCPMC6104308
OpenAlexW2888681428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.